Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination therapy for rheumatoid arthritis].

Jean Sibilia1

  • 1Service de Rhumatologie, Hôpital de Hautepierre, CHU, 67098 Strasbourg Cedex, France. jean.sibilia@wanadoo.fr

Annales De Medecine Interne
|May 8, 2002
PubMed
Summary

Combination therapy for rheumatoid arthritis aims to improve treatment efficacy and patient outcomes. Clinical trials assess various drug combinations to optimize long-term disease control and joint preservation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

RMD open·2026
Same author

Inviting ecosystems into the exposome framework.

Exposome·2026
Same author

Acute myocarditis after switching between two adalimumab biosimilars.

Rheumatology (Oxford, England)·2026
Same author

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

Annals of the rheumatic diseases·2026
Same author

[French medical studies: Educational reforms since 2018].

La Revue du praticien·2026
Same author

Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms.

European journal of neurology·2026

Area of Science:

  • Rheumatology
  • Clinical Pharmacology
  • Immunology

Context:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
  • Effective management of RA often requires strategies beyond monotherapy.
  • Combination therapy presents a promising approach to enhance treatment outcomes in RA patients.

Purpose:

  • To explore the expected outcomes and goals of combination therapy in rheumatoid arthritis management.
  • To identify criteria for selecting appropriate drug combinations for RA.
  • To review clinical trial data on assessed combination therapies and their long-term contributions.

Summary:

  • Combination therapy in RA aims to achieve superior disease control and prevent joint damage compared to monotherapy.
  • Drug selection for combination regimens is guided by efficacy, safety profiles, and patient-specific factors.
  • Clinical trials have evaluated numerous combination therapies, with prolonged use showing potential for sustained remission and functional improvement.

Impact:

  • Optimizing combination therapy strategies can lead to improved quality of life for rheumatoid arthritis patients.
  • Understanding the long-term benefits of combination therapy can inform clinical practice and treatment guidelines.
  • This review provides insights into the evolving landscape of RA treatment through combination drug approaches.

Related Experiment Videos